IFNA2 and COVID-19: Raadsen et al.[54] showed that anti-IFN-α2 antibodies in COVID-19 CP donors were not neutralizing, thus suggesting that despite the positivity of ELISA, these antibodies may have a low influence on outcomes once they are transfused.